Elsevier Brings Together Leading Experts from around the World For DIAMOND 2011 Conference
Conference will focus on the fields of diamond, diamond-like compounds, carbon nanotubes, graphene, and nitrides
New York, NY, 10 January 2011 – Elsevier announced today that DIAMOND 2011, 22nd European Conference on Diamond, Diamond-Like Materials, Carbon Nanotubes and Nitrides, will occur on 4-8 September 2011 in Garmisch-Partenkirchen, Bavaria, Germany. The Elsevier organized conferencediscusses the significant improvements in material growth processes, material purity and doping of these materials over the past few years. The improvements have lead to the discovery of new phenomena in these materials as well as to novel device applications with increasingly impressive performance levels.
The conference is now accepting abstracts for oral and paper presentations in the topics of diamond, diamond-like carbon, carbon nanotubes, graphene, and III-nitrides: growth properties and applications. Abstract submissions should be made through the online abstract submission system at www.diamond-conference.elsevier.com. The deadline for abstract submission is March 3, 2011.
“Elsevier is very excited to be organizing DIAMOND 2011 in collaboration with the scientific community,” said Allyn Molina, Elsevier Publisher. “Building on the success of last year’s conference, the program will continue to bring a broad spectrum of speakers and topics that present the current state of diamond science.”
"In 2011 we expect significant progress with respect to single crystalline diamond wafer production as well as quantum effects in diamond applied for quantum computing, cryptography and magnetic field sensing,” commented Christoph Nebel, conference Chair and Professor at Fraunhofer Institut für Angewandt Festkörperphysik (IAF), Germany. “These topics are at the leading edge of semiconductor research, utilizing the unique properties of diamond for novel semiconductor applications of the near future and will be addressed at DIAMOND 2011."
Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a world-leading provider of information and analytics to professionals and business customers, in a wide range of industries. www.elsevier.com
+1 212 633-3103